Minimally invasive Ennovate® method for cervical pedicle screw placement
Official title: Controlled, Randomized Clinical Study to Demonstrate the Patient Benefit and Safety of Pedicle Screw Placement Through an Innovative Minimally Invasive Surgical Approach Using the Ennovate® Cervical Spinal System
Run by Aesculap AG · NCT06960018 · Data updated 2026-11-12
This project tests whether the minimally invasive Ennovate® method for placing cervical pedicle screws is safe and helps adults who need posterior cervical fusion.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Aesculap AG Industry-sponsored |
| Locations | 3 sites (Aachen and 2 other locations) |
| Status | Recruiting |
| Started | June 20, 2025 |
| Main results expected | November 2027 |
| Study ends | November 2028 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT06960018 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older scheduled to receive Ennovate® Cervical internal fixation between C2 and Th3 for restoration and stabilization of the cervical spine who can provide consent and attend routine follow-up are ideal candidates.
✕Probably not a fit
Patients with severe bone disorders (for example severe osteoporosis or Paget's disease), active vertebral infection, suspected allergy to implant materials, or those unable to comply with follow-up are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study collects clinical data comparing a minimally invasive Ennovate® cervical pedicle screw technique to the standard open surgical approach for posterior cervical fusion. Adult patients (age ≥18) receiving Ennovate® Cervical internal fixation between C2 and Th3 will be enrolled and followed for safety, implant stability, and recovery outcomes. Surgeons will use either the minimally invasive or open technique with the Ennovate® Cervical Spinal System and outcomes will include complication rates, radiographic stability, and patient-centered measures such as pain and return to function. Routine postoperative follow-up visits will capture clinical and device-related data to inform benefit and risk profiles.
Why it matters
Potential benefit: If successful, the minimally invasive approach could reduce tissue damage, shorten hospital stays, and speed recovery while maintaining spinal stability.
How similar studies have gone: Minimally invasive pedicle screw techniques elsewhere in the spine have shown reduced blood loss and faster recovery, but minimally invasive cervical pedicle fixation with the Ennovate® method is relatively novel and has limited published clinical data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with minimum 18 years of age receiving Ennovate® Cervical internal fixation device within the vertebral bodies C2-Th3 to ensure the restoration and stabilization of the cervical spine Exclusion Criteria: * All patients not willing to sign the patient consent are excluded. Also, if it is clear from the beginning, that the patient will not be able to come to routine follow-up, the patient will also be excluded. Absolute contraindications according to the IFU: * Severe damage to the bone structures of the spine that could prevent the stable implantation of the implant components; for example, osteopenia, severe osteoporosis, Paget's disease, bone tumors etc. * Metabolic or degenerative metabolic bone diseases that could compromise the stable anchoring of the implant system. * Suspected allergy or sensitivity to the implant materials. * Acute or chronic vertebral infections of a local or systemic nature. * Poor patient compliance or limited ability to follow medical instructions, particularly in the postop phase, including with regard to the restrictions on range of movement in terms of physical exercise and occupational activity.
Where it's running
-
Universitätsklinikum Aachen
Aachen, Germany Recruiting -
Charité Berlin
Berlin, Germany Recruiting -
Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany Recruiting
Study contacts
- Study coordinator: Sarah Mattes
- Email: studies@aesculap.de
- Phone: +497461
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-Volume PENG Block With Dexamethasone After Hip Replacement
This trial tests whether a smaller PENG block with dexamethasone provides similar pain relief but preserves quadriceps strength after hip replacement, compared with the standard-volume PENG block.
-
Analgesia after open inguinal hernia repair using intrathecal morphine or a transversalis fascia plane block
This trial tests whether intrathecal morphine or a ultrasound-guided transversalis fascia plane block can provide better pain relief after open inguinal hernia repair in adults.
-
Single-level vs two-level erector spinae plane block for breast surgery
This study tests whether a single-level ESPB provides similar pain relief to a two-level ESPB for adults undergoing breast surgery.
-
Transverse vs Longitudinal Serratus Anterior Plane Block for Breast Surgery
This trial tests whether a longitudinal ultrasound view for serratus anterior plane block provides better pain relief after breast surgery than the standard transverse view.
-
iPAWS: Helping teens manage pain and risky behaviors after wisdom tooth removal
This program tests a short online intervention to help teens and their parents handle post-surgical pain and reduce risky behaviors after wisdom tooth extraction.
-
Single-shot nerve block with IV dexamethasone for rebound pain after shoulder surgery
This trial tests whether giving a one-time shoulder nerve block plus an IV dexamethasone dose can prevent rebound pain after shoulder surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.